China Orthopedic Device Industry Report, 2011-2012

Benefiting from the rise in income level, the advent of the population aging era, improvement of medical reimbursement ratio, etc., the market demand of Chinese orthopedic device industry has been effectively released. In 2006-2011, China’s market size of orthopedic devices grew at a CAGR of 20.5% to RM8.32 billion. Trauma product, spine product and joint product are three product segments among Chinese orthopedic devices

At present, the orthopedic device industry features a low degree of concentration in China, with market share of local enterprises lagged behind that of foreign peers, and the high-end market is almost occupied by foreign manufacturers of medical devices. In 2011, China’s leading orthopedic devices companies like Trauson Holdings Company Limited, China Kanghui Holdings, Weigao Group respectively held a market share of merely 4.6%, 3.9% and 2.9%. Nevertheless, Chinese companies are constantly increasing investment in R&D and production technology, as well as relying on cost and channel advantages to seize the market; while foreign counterparts are accelerating the localization process there via direct investment in factories, joint ventures, acquisitions and other ways. 

China Orthopedic Device Industry Report, 2011-2012 mainly covers the followings:

• Market size, import & export, profit level, competitive landscape, etc.;
• Regulation policies, industry policies, entry barriers, influence from upstream and downstream sectors, etc.;
• Development situation and forecast, including the overall market as well as three main segments, i.e., trauma product, spine product and joint prosthesis;
• Production & operation, investment, mergers & acquisitions, orthopedic device business development, etc. of 13 major orthopedic device companies (involving four foreign ones) in China.